宜明昂科-B(01541.HK):公司擬參與H股全流通計劃
格隆匯10月25日丨宜明昂科-B(01541.HK)公吿,中國證監會於2019年11月14日發佈並於2023年8月10日進一步修訂的《H股公司境內未上市股份申請"全流通"業務指引》("指引"),內容有關H股於聯交所上市的公司的境內未上市股份在聯交所上市流通的程序。
基於該指引,公司董事會欣然宣佈,於2024年10月25日,公司已就擬實施H股全流通("H股全流通")向中國證監會提交備案文件,以轉換合共14,114,006股公司未上市股份為公司H股。
待取得所有相關批准(包括中國證監會的備案通知及聯交所的批准)及符合所有適用法律、法規及規則後,該等未上市股份將轉換成H股,且公司將申請該等H股於聯交所主板上市及買賣。根據公司的組織章程細則,毋須就批准轉換及上市另行召開股東大會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.